Acthéane Tablets for Hot Flashes 120 Tablets

Acthéane Tablets for Hot Flashes

Acthéane is a homeopathic remedy by Boiron designed to alleviate hot flashes and other symptoms associated with menopause. Its gentle formulation provides relief without the need for hormones, making it a natural choice for women experiencing menopausal symptoms.

Key Features:

• Natural Ingredients: Acthéane is composed of a blend of homeopathic remedies, including Belladonna, Lachesis muta, and Sepia officinalis. These ingredients are known for their ability to reduce hot flashes, night sweats, and irritability, providing comfort during menopause.

• Non-Hormonal Relief: Acthéane's formula is hormone-free, making it an ideal option for women seeking a natural remedy for menopausal symptoms without hormonal side effects.

• Convenient Tablets: Acthéane comes in tablet form, making it easy to take throughout the day. Simply dissolve a tablet under the tongue for rapid absorption.

• No Known Side Effects: The natural formulation minimizes the risk of side effects, making Acthéane safe for everyday use. The product is free from artificial additives and preservatives.

• Trusted Brand: Boiron is a renowned name in the homeopathic industry, with decades of experience delivering high-quality, natural health products. Acthéane upholds this tradition, offering reliable relief for menopausal symptoms.

Directions for Use:

Take one tablet under the tongue at the onset of symptoms, up to three times daily, or as directed by a healthcare professional.

Please read the following full disclosure before purchasing or using these tablets.

Summary of Product Characteristics

1. Name of the Medicinal Product:

Acthéane Tablets for Hot Flashes by Boiron

2. Qualitative and Quantitative Composition:

• Belladonna 4 CH: 1g
• Lachesis muta 4 CH: 1g
• Sepia officinalis 4 CH: 1g
• Glonoinum 4 CH: 1g

Each tablet contains these ingredients.

3. Pharmaceutical Form:

Tablet

4. Clinical Particulars:

4.1 Therapeutic Indications:

For the relief of hot flashes and other symptoms associated with menopause, including night sweats, irritability, and mood swings.

4.2 Posology and Method of Administration:

• Adults (women): Take one tablet under the tongue at the onset of symptoms, up to three times daily, or as directed by a healthcare professional.
• Not suitable for children or men.

4.3 Contraindications:

• Hypersensitivity to any of the ingredients.

4.4 Special Warnings and Precautions for Use:

• Consult a healthcare professional if symptoms persist or worsen.

4.5 Interactions with Other Medicinal Products and Other Forms of Interaction:

• No known interactions. Consult a healthcare professional before combining with other medications.

4.6 Fertility, Pregnancy, and Lactation:

• This product is designed for women experiencing menopause. Consult a healthcare professional before use if pregnancy or lactation is possible.

4.7 Effects on Ability to Drive and Use Machines:

• None known.

4.8 Undesirable Effects:

• None known. If adverse effects occur, discontinue use and consult a healthcare professional.

4.9 Overdose:

• Overdose is unlikely. In case of accidental ingestion of multiple tablets, seek medical advice.

5. Pharmacological Properties:

5.1 Pharmacodynamic Properties:

• The homeopathic ingredients in Acthéane, including Belladonna, Lachesis muta, and Sepia officinalis, work together to alleviate hot flashes, night sweats, and other menopausal symptoms.

5.2 Pharmacokinetic Properties:

• No specific pharmacokinetic data available for homeopathic remedies.

6. Pharmaceutical Particulars:

6.1 List of Excipients:

• Sucrose, lactose, magnesium stearate.

6.2 Shelf Life:

• Check the expiration date on the package.

6.3 Special Precautions for Storage:

• Store at room temperature, away from direct sunlight and moisture.

6.4 Nature and Contents of the Container:

• Available in a blister pack containing 60 tablets.

6.5 Special Precautions for Disposal:

• Dispose of unused tablets in accordance with local regulations.

7. Marketing Authorization Holder:

BOIRON

8. Date of Revision:

April 2024